Company Overview
Sinclair Pharma Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Thursday 29 July 1999, so this is a well established company. Sinclair Pharma Limited has been in business for 26 years and 8 months. The accounts status is group and the accounts are next due on Wednesday 30 September 2026.
Registered Address

Whitfield Court, 30 -32 Whitfield Street, London, W1T 2RQ
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameSINCLAIR PHARMA LIMITED
Company Number03816616
Registered Office AddressWhitfield Court
 30 -32 Whitfield Street
 W1T 2RQ
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date29/07/1999
Accounting Reference Date Day31
Accounting Reference Date Month12
Accounts Next Due Date30/09/2026
Accounts Last Made Up Date31/12/2024
Accounts Account CategoryGROUP
Returns Next Due Date04/01/2017
Returns Last Made Up Date07/12/2015
Previous Company NameChanged Date
SINCLAIR IS PHARMA PLC17 Dec 2015
SINCLAIR PHARMA PLC23 Jun 2011
Directors & Members
Show Resigned
Jianing Hu - Director
(Chinese, 30 years old, born April 1996)
Appointed 18 May 2025
Active
Gen Li - Director
(Chinese, 37 years old, born November 1989)
Appointed 27 April 2023
Active
Renbo Qiu - Director
(Chinese, 44 years old, born July 1982)
Appointed 10 October 2024
Active
Zhongxing Zhang - Director
(Chinese, 44 years old, born September 1982)
Appointed 10 June 2025
Active
Zhaohua Zhou - Director
(Chinese, 56 years old, born February 1970)
Appointed 23 August 2023
Active
Secretaries
Show Resigned
Other Company Directorships
Jianing Hu
No companies found
Gen Li
No companies found
Renbo Qiu
No companies found
Zhongxing Zhang
No companies found
Zhaohua Zhou
No companies found
Balance Sheet Unlock full report
Accounts Date 31-Dec-2024 30-Jun-2015 30-Jun-2014
Balance Sheet
Fixed Assets 237,469,000 237,469,000 246,950,000
Current Assets 47,948,000 47,948,000 55,768,000
Creditors Due Within One Year 46,747,000 46,747,000 42,875,000
Working Cap 1,201,000 1,201,000 12,893,000
Total Assets Less Current Liabilities 238,670,000 238,670,000 259,843,000
Long-term Liabilities 133,098,000 133,098,000 141,926,000
Net Assets 105,572,000 105,572,000 117,917,000
Share Capital & Reserves
Share Cap 4,974,000 4,974,000 4,974,000
Profit & Loss Reserves -75,943,000 -75,943,000 -70,162,000
Other Reserves 176,541,000 176,541,000 183,105,000
Shareholders Funds 105,572,000 105,572,000 117,917,000
Common Size Financial Analysis Unlock full report
Accounts Date 31-Dec-2024 30-Jun-2015 30-Jun-2014
Tangible Fixed Assets - - -
Fixed Assets 83.2% 83.2% 81.6%
Stocks Inventory 2.7% 2.7% 2.5%
Debtors 8.6% 8.6% 8.3%
Cash Bank In Hand 4.4% 4.4% 5.8%
Current Assets 16.8% 16.8% 18.4%
Creditors Due Within One Year 16.4% 16.4% 14.2%
Net Current Assets Liabilities 0.4% 0.4% 4.3%
Creditors Due After One Year 46.6% 46.6% 46.9%
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability 37.0% 37.0% 39.0%
Called Up Share Capital 1.7% 1.7% 1.6%
Share Capital Allotted Called Up Paid 1.7% 1.7% 1.6%
Profit Loss Account Reserve -26.6% -26.6% -23.2%
Shareholder Funds 37.0% 37.0% 39.0%
Capital Employed - - -
Total Assets Less Current Liabilities 83.6% 83.6% 85.8%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Dec-2024 30-Jun-2015 30-Jun-2014
Liquidity Ratio 1.0 1.0 1.3
Solvency Ratio 1.6 1.6 1.6
Reserves to Assets -0.3 -0.3 -0.2
Secured Creditors Unlock full report
Mortgages Charges 14
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 14
Assets and Debt Analysis Unlock full report
Accounts Date 31-Dec-2024 30-Jun-2015 30-Jun-2014
Assets 285,417,000 285,417,000 302,718,000
Debt 179,845,000 179,845,000 184,801,000
Net Assets/Debt 105,572,000 105,572,000 117,917,000

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The current section of the balance sheet has positive working capital. We would normally consider this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet indicates the substantial net assets of a large company. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The current section of the balance sheet has positive working capital. We would normally consider this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet indicates the substantial net assets of a large company. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The current section of the balance sheet has positive working capital. We would normally consider this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet indicates the substantial net assets of a large company. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due
Paid After
30 days due
Owing Before
30 days due
Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.

Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around W1T 2RQ
SINCLAIR PHARMA MAN CO LIMITED
C/O Mazars Llp, 45 Church Street, Birmingham, W1T 2RQ
I-MEDIA ADVERTISING LTD
30-32 3rd Floor, Whitfield Court, Whitfield Street, London, W1T 2RQ
PITSTOP ADVERTISING LIMITED
ELSLEY COURT, 20-22 GREAT TITCHFIELD STREET, LONDON, W1T 2RQ
SINCLAIR PHARMA HOLDINGS LIMITED
1ST FLOOR, WHITFIELD COURT 30-32 WHITFIELD STREET, LONDON, W1T 2RQ
SINCLAIR PHARMA MANAGEMENT LIMITED
1ST FLOOR WHITFIELD COURT, 30-32 WHITFIELD STREET, LONDON, W1T 2RQ
Document Filings
Registered office address changed from , Whitfield Court 30 -32 Whitfield Street, London, W1T 2RQ to Eden House Lakeside Chester Business Park Chester CH4 9QT on 12 March 2026
Notification of a person with significant control statement
Cessation of Kaijun Hu as a person with significant control on 19 November 2018
Confirmation statement made on 18 June 2025 with no updates
Appointment of Mr Zhongxing Zhang as a director on 10 June 2025
Appointment of Ms Jianing Hu as a director on 18 May 2025
Termination of appointment of Amber Rebecca Edwards as a director on 5 June 2025
Appointment of Mr Renbo Qiu as a director on 10 October 2024
Termination of appointment of Jayne Katherine Burrell as a secretary on 9 December 2024
Termination of appointment of Chengwei Liu as a director on 10 October 2024
Appointment of Ms Amber Rebecca Edwards as a director on 30 September 2024
Termination of appointment of Miguel Angel Pardos Blanco as a director on 30 September 2024
Termination of appointment of Jun Huang as a director on 4 September 2024
Director's details changed for Mrs Jun Huang on 18 April 2024
Confirmation statement made on 18 June 2024 with no updates
Director's details changed for Mrs Jun Huang on 16 January 2024
Appointment of Mrs Jun Huang as a director on 23 August 2023
Appointment of Mrs Zhaohua Zhou as a director on 23 August 2023
Termination of appointment of Bo Chen as a director on 23 August 2023
Confirmation statement made on 18 June 2023 with no updates
Appointment of Mr Gen Li as a director on 27 April 2023
Termination of appointment of Shizheng Duan as a director on 27 April 2023

In using this service you agree to the Terms and Conditions

© 2026 Check Free